BARR RECEIVES APPROVAL FOR GENERIC XANAX XR TABLETS

Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc., announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market a generic version of Pfizer Inc.'s XANAX XR (Alprazolam Extended-Release) Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The company intends to launch its product immediately.
Yahoo Finance